Alzheimer’s Disease: We’re Not About to Give Up Now

Worldwide's CSO and CMO discuss outcomes complexities in Alzheimer's clinical trials

Read more

In this video, Dr. Michael Murphy shares his thoughts on understanding the complexities in evaluating patients with various phenotypes and implementing study design features that mitigate risks and challenges.


Chief Medical and Scientific Officer

Want to learn more about Worldwide Clinical Trials?